Skip to main content
. 2019 Sep;48(9):1566–1576.

Table 1:

Characteristics of published studies on tea consumption and lung cancer risk

Study Study period Country Study design Case-control or cohort Tea type OR (95%CI) NOS score (stars)
Romain 2016(14) 1996–2001 Canada PCC 1111/1469 Black 0. 71[0. 61, 0. 83] 8
Wu 2015(15) 2001–2010 China PCC 117/1196 Green 0. 87[0. 70, 1. 07] 7
Wang 2015(16) 2012–2014 China HCC 88/84 Tea 0. 97[0. 53, 1. 76] 7
Mai 2015(17) 1992–2011 US Cohort 1137/94887 Tea 0. 83[0. 71, 0. 96] 8
Katarzyna 2015(18) 2014 Poland PCC 92/156 Green 0. 49[0. 26, 0. 93] 7
Bao 2014(18) 2010–2013 China HCC 50/50 Green 0. 22[0. 08, 0. 60] 7
Rup 2014(20) 2009–2012 India PCC 230/460 Tea 0. 95[0. 61, 1. 49] 7
P. gnagna 2013(22) 2004–2005 Italy Cohort 178/4158 Tea 0. 72[0. 52, 0. 99] 8
Xu 2013(21) 2006–2012 China HCC 1225/1234 Tea 0. 98[0. 84, 1. 15] 7
Yumie 2013(23) 2002–2009 China Cohort 359/60733 Tea 0. 66[0. 53, 0. 83] 7
Jin 2013(24) 2003–2010 China PCC 1424/4543 Green 1. 05[0. 92, 1. 20] 8
Yumiel 2013(25) 2001–2011 China Cohort 428/70839 Tea 1. 00[0. 81, 1. 23] 7
Lin 2012(26) 2004–2008 China HCC 170/340 Green 0. 34[0. 21, 0. 55] 7
Zhang 2012(27) 1997–2009 China PCC 900/133811 Tea 1. 16[1. 01, 1. 32] 8
Bganesh 2011(28) 1997–1999 India HCC 408/1383 Tea 0. 24[0. 11, 0. 55] 6
Jiang 2011(29) 2009–2011 China HCC 100/100 Tea 0. 92[0. 53, 1. 61] 7
Lu 2009(30) 1992–1995 US Cohort 201/38207 Tea 0. 81[0. 61, 1. 08] 7
Han 2008(31) 2003–2008 China HCC 523/1924 Green 0. 56[0. 44, 0. 73] 7
Zhang 2008(32) 2002–2006 China PCC 505/529 Tea 1. 16[0. 89, 1. 53] 8
Wang 2008(24) 2006 China HCC 363/363 Tea 0. 60[0. 44, 0. 82] 7
Qli 2008(33) 1994–2001 Japan cohort 302/41138 Green 1. 29[0. 98, 1. 69] 8
Yan 2008(35) 1999–2004 US PCC 558/837 Green&Black 0. 52[0. 42, 0. 66] 7
Tao 2007(36) 2002–2006 China HCC 47/94 Tea 0. 72[0. 31, 1. 70] 6
Shinchi 2006(4) 1995–2005 Japan Cohort 222/16247 Green 1. 13[0. 82, 1. 56] 8
Hu 2002(39) 1994–1997 Canada PCC 161/483 Tea 0. 52[0. 34, 0. 81] 8
Mattew 2005(37) 1995–1996 China PCC 122/121 Green 0. 83[0. 44, 1. 54] 7
Ja 2005(38) 1982–1998 US PCC 993/986 Black 0. 95[0. 79, 1. 13] 6
Nagano 2001(41) 1979–1994 Japan Cohort 395/35930 Green 0. 86[0. 66, 1. 12] 9
Zhong 2001(40) 1992–1994 China PCC 649/675 Green 0. 97[0. 74, 1. 26] 7
Hivonen 2001(42) 1995–1998 Finland PCC 791/25643 Tea 0. 66[0. 53, 0. 81] 7
Kei 2000(3) 1986–1997 Japan Cohort 69/9483 Green 1. 01[0. 62, 1. 63] 6
Ki 1997(45) 1992–1993 China HCC 105/105 Tea 0. 50[0. 23, 1. 10] 7
Fredrik 1998(43) 1989–1995 Sweden PCC 124/235 Black 1. 23[0. 78, 1. 96] 8
Maria 1998(44) 1994–1996 Uruguay HCC 427/428 Black 0. 78[0. 60, 1. 02] 7
Alexandra 1996(46) 1986–1990 Netherlands Cohort 764/120088 Black 0. 58[0. 49, 0. 70] 8
Zheng 1996(47) 1986–1993 US Cohort 312/35057 Black 0. 78[0. 62, 0. 99] 7
Gosta 1996(48) 1989–1993 Sweden PCC 308/504 Black 0. 71[0. 53, 0. 94] 7
Xu 1996(49) 1987–1993 China PCC 598/926 Tea 0. 84[0. 68, 1. 03] 9
Ohno 1995(50) 1988–1991 Japan PCC 333/666 Tea 0. 57[0. 39, 0. 83] 9
Tewes 1990(51) 1981–1983 China PCC 200/200 Green&Black 0. 98[0. 66, 1. 45] 6
Mettlin 1989(52) 1982–1987 US HCC 569/569 Tea 0. 71[0. 56, 0. 91] 6
Kinlen 1988(53) 1969–1986 UK Cohort 718/12868 Tea 1. 67[1. 31, 2. 13] 7

PCC, population-based case-control study; HCC, hospital-based case-control study; US, United States; UK, United Kingdom